1-deoxysphinganine	(1-deoxySA)
2-hydroxybiphenyl	(2HBP)
8-pentamethoxyisoflavan	(HPMF)
adenosine monophosphate-activated protein kinase	(AMPK)
alkylacyl phosphatidylcholines	(PCe)
alkylacyl phosphatidylethanolamines	(PEe)
amino acids	(AA)
area-under-curve	(AUC)
Atherosclerosis Risk in Communities	(ARIC)
branched-chain a-ketoacid dehydrogenase	(BCKD)
branched-chain amino acid aminotransferase	(BCATm)
branched-chain aminotransferase	(BCATm)
branched-chain keto acid dehydrogenase	(BCKDH)
branched-chained AA	(BCAA)
branched-chain-OA	(BCOA)
Ceramides	(Cer)
cholesterol esters	(CE)
cholesterol esters	(ChoE)
cholesteryl ester	(CE)
choline ether phospholipid	(PCae)
combined glucose tolerance	(CGT)
Cooperative Health Research in the Region of Augsburg	(KORA)
coronary artery disease	(CAD)
deoxysphingosine	(1-deoxySO)
diabetes mellitus	(DM)
diabetic nephropathy	(DN)
diabetic retinopathy	(DR)
diacylglycerols	(DAG)
dihydroceramides	(DHC)
Dongfeng-Tongji	(DFTJ)
endogenous glucose production	(EGP)
European Prospective Investigation into Cancer and Nutrition	(EPIC)
False Discovery rate	(FDR)
farnesoid X receptor	(FXR)
fold change	(FC)
Free Fatty Acid Receptor 2	(FFAR2)
Free fatty acids	(FFA)
Gestational diabetes	(GDM)
glucagon-like peptide-1	(GLP-1)
glucose-6-phosphotase	(G6P)
glycated hemoglobin	(HbA1c)
glycerophospholipids	(GPL)
G-protein-coupled receptors	(GPCR)
Health Professionals Follow-Up Study	(HPFS)
High-density-lipoprotein-cholesterol	(HDL-C)